Novo Nordisk Inc.
H‑1B Sponsor Verified
Yes. Novo Nordisk Inc. filed 59 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2019–2026, including 2 so far in 2026. The average H-1B salary is $146,609 and the most sponsored role is Clinical Site Lead.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: Feb 26, 2026.
LinkedIn ↗Latest Year Filings
2
In 2026
↗ Filter by year
Total H‑1B Filings
59
Since 2020
↗ View records
Avg Annual Salary
$146,609
All years combined
↗ View chart
Top Role
Clinical Site Lead
↗ Click to filter
Filing trend
H‑1B filings by year for Novo Nordisk Inc.
| Year | LCA filings | Avg salary |
|---|---|---|
| 2026 | 2 | $160,750 |
| 2024 | 11 | $153,131 |
| 2023 | 12 | $163,997 |
| 2022 | 9 | $146,534 |
| 2021 | 10 | $136,055 |
| 2020 | 13 | $130,302 |
| 2019 | 2 | $151,377 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary